Emerging Therapies and Management Strategies of MDS and Myeloid Malignancies for Nurses
Activity Release Date: 11/09/2020
Activity Expiration Date: 11/09/2021
Estimated Time to Complete Activity: 1.5 hours
This course is accredited for Nurses
Description:
This program was recorded at the ONS Bridger on September 17, 2020 and is targeted to clinical nursing professionals in oncology. Case studies were used to illustrate treatment decision-making and therapeutic challenges.
Presenters:
Christina Cline, RN, BSN, CCRC, Senior Registered Nurse Manager, University of Florida, Gainesville, FL
Allyson Price, MPAS, PA-C, Physician Assistant, The University of Texas MD Anderson Cancer Center, Houston, TX
Kirsten Roblee, RN, BSN, OCN, Assistant Nurse Manager, The James Cancer Hospital and Solove Research Institute, Columbus, OH
Target Audience
This activity is intended for nurses and nurse practitioners who are involved in the treatment or management of patients with bone marrow failure disease.
Learning Objectives
After completing this activity, the participant should be better able to:
Providers
This CE activity is jointly provided by Medical Learning Institute, Inc. and the Aplastic Anemia and MDS International Foundation.
Commercial Support Acknowledgement
This activity is supported by an independent educational grant from Celgene Corporation, a Bristol Myers Squibb company.
Target Audience
This activity is intended for nurses and nurse practitioners who are involved in the treatment or management of patients with bone marrow failure disease.
Registered Nurse Education
The Medical Learning Institute, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Centerʼs Commission on Accreditation. Successful completion of this continuing nursing education activity will be awarded 1.5 contact hours.
Disclosure & Conflict of Interest Policy
The Medical Learning Institute, Inc. (MLI) requires faculty, planners, staff, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they, and their spouse/life partners, may have as related to the content of this activity. These disclosures will be provided to learners prior to the start of the activity. All identified COI are thoroughly vetted and resolved according to MLI policy. MLI is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Faculty Disclosures
Christine Cline, RN, BSN, CCRC, has nothing to disclose.
Kirsten Roblee, RN, BSN, OCN, has nothing to disclose.
Alyson Price, MPAS, PAC, has nothing to disclose.
Planning Committee Disclosures
The planners from Medical Learning Institute, Inc., the accredited provider, and Aplastic Anemia and MDS International Foundation the joint provider, do not have any financial relationships with an ACCME-defined commercial interest related to the content of this accredited activity during the past 12 months unless listed below.
Tracy L. Greene, MSN, RN, FNP-C, Nurse Planner, MLI, has nothing to disclose.
Alice Houk, MPS, AAMDSIF, has nothing to disclose.
Content/Peer Reviewer Disclosures
Stacy Sims, MSN, RN, CMCN, has nothing to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in and receiving credit for this activity. Participants must:
Additional Resources
Activity Expiration Date: 11/09/2021
Estimated Time to Complete Activity: 1.5 hours
This course is accredited for Nurses
Description:
This program was recorded at the ONS Bridger on September 17, 2020 and is targeted to clinical nursing professionals in oncology. Case studies were used to illustrate treatment decision-making and therapeutic challenges.
Presenters:
Christina Cline, RN, BSN, CCRC, Senior Registered Nurse Manager, University of Florida, Gainesville, FL
Allyson Price, MPAS, PA-C, Physician Assistant, The University of Texas MD Anderson Cancer Center, Houston, TX
Kirsten Roblee, RN, BSN, OCN, Assistant Nurse Manager, The James Cancer Hospital and Solove Research Institute, Columbus, OH
Target Audience
This activity is intended for nurses and nurse practitioners who are involved in the treatment or management of patients with bone marrow failure disease.
Learning Objectives
After completing this activity, the participant should be better able to:
- Explain the role of genetic testing in diagnosing, stratifying and treating myeloid malignancies
- Identify emerging treatment options for patients with low-risk MDS, high-risk MDS, and secondary AML
- Analyze the nurse’s role in managing treatment for myeloid malignancies based on clinical presentations, diagnostic workups, transfusion dependence, and comorbidities
- Discuss the nurse’s role in collaboration with other disciplines in addressing treatment goals and providing patient education to improve outcomes.
Providers
This CE activity is jointly provided by Medical Learning Institute, Inc. and the Aplastic Anemia and MDS International Foundation.
Commercial Support Acknowledgement
This activity is supported by an independent educational grant from Celgene Corporation, a Bristol Myers Squibb company.
Target Audience
This activity is intended for nurses and nurse practitioners who are involved in the treatment or management of patients with bone marrow failure disease.
Registered Nurse Education
The Medical Learning Institute, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Centerʼs Commission on Accreditation. Successful completion of this continuing nursing education activity will be awarded 1.5 contact hours.
Disclosure & Conflict of Interest Policy
The Medical Learning Institute, Inc. (MLI) requires faculty, planners, staff, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they, and their spouse/life partners, may have as related to the content of this activity. These disclosures will be provided to learners prior to the start of the activity. All identified COI are thoroughly vetted and resolved according to MLI policy. MLI is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Faculty Disclosures
Christine Cline, RN, BSN, CCRC, has nothing to disclose.
Kirsten Roblee, RN, BSN, OCN, has nothing to disclose.
Alyson Price, MPAS, PAC, has nothing to disclose.
Planning Committee Disclosures
The planners from Medical Learning Institute, Inc., the accredited provider, and Aplastic Anemia and MDS International Foundation the joint provider, do not have any financial relationships with an ACCME-defined commercial interest related to the content of this accredited activity during the past 12 months unless listed below.
Tracy L. Greene, MSN, RN, FNP-C, Nurse Planner, MLI, has nothing to disclose.
Alice Houk, MPS, AAMDSIF, has nothing to disclose.
Content/Peer Reviewer Disclosures
Stacy Sims, MSN, RN, CMCN, has nothing to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in and receiving credit for this activity. Participants must:
- Read the learning outcomes and faculty disclosures
- Watch and study the educational activity
- Successfully complete the Nursing CE Assessment with a score of 70% or better
- Complete the evaluation form
- Once you’ve completed the appropriate steps and scored a 70% or greater, you will be able to download/print your certificate
Additional Resources
- MDS Toolkit – newly designed and updated MDS Toolkit with materials to help educate and support patients and their caregivers wherever they are in their MDS journey. Resources include patient information pages, disease management tools, and AAMDSIF booklets and fact sheets
- 2020 Bone Marrow Failure Disease Scientific Symposium – Free access to all on-demand content from our 2020 symposium, including sessions on Genetics and Genomics, Transplant and Non-Transplant Treatments, and Treatments for MDS and Secondary AML
- AAMDSIF Resources for Professionals – links to free CE programs
- AAMDSIF Patient Referral Form – connect patients and caregivers directly to AAMDSIF for ongoing education and support
- AAMDSIF Patient Education Materials Order Form – complete list of free patient education materials